| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/19/1994 | EP0578768A1 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress. |
| 01/19/1994 | EP0578732A1 Chewable antacid compositions. |
| 01/19/1994 | EP0439453B1 Improved method for treatment of gastrointestinal disorders |
| 01/19/1994 | CN1080931A Calcium channel blocking polypeptides from filistata hibernalis |
| 01/19/1994 | CN1080916A Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 01/19/1994 | CN1080851A Agent for increasing somatostatin or for inhibiting decrease of somato statin |
| 01/18/1994 | US5280107 Using an anioic exchanger |
| 01/18/1994 | US5280030 Containing 1-benz(oxazole, thiazole or imidazole)-4-imidazole piperidine compound |
| 01/18/1994 | CA2100399A1 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 01/16/1994 | CA2099294A1 N-substituted anilines |
| 01/16/1994 | CA2073917A1 Fused benzeneoxyacetic acid derivatives |
| 01/12/1994 | EP0578477A1 Treatment of inflammatory bowel disease |
| 01/12/1994 | EP0577957A1 8-Chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 01/12/1994 | EP0577904A1 Lactic bacteria |
| 01/12/1994 | EP0577903A1 Agent antigastrite contenant lactobacillus acidophilus |
| 01/12/1994 | EP0577847A1 Morphinan derivative and medicinal use |
| 01/12/1994 | EP0577726A1 Fat substitute compositions having reduced laxative effects |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5278288 Contacting milk raw materials containing the glycomacropeptide with cation exchanger to adsorb a fraction of the material, collecting a nonadsorbed fraction, concentrating and desalting the fraction |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | US5277902 Administering orally with or without silica gel |
| 01/11/1994 | CA1326108C Cck antagonists |
| 01/11/1994 | CA1326018C Method for preparing high purity cristalline lactulose and the product obtained |
| 01/08/1994 | CA2099789A1 Treatment of inflammatory bowel disease |
| 01/06/1994 | WO1994000453A1 Purinone antianginal agents |
| 01/06/1994 | WO1994000451A1 9-AMINOPYRIDAZINO[4',5' : 3,4]pyrrolo[2,1-a]ISOQUINOLINES AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS |
| 01/06/1994 | WO1994000437A1 Pharmaceutical pyridine compounds |
| 01/06/1994 | WO1994000435A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
| 01/06/1994 | WO1994000417A1 Zinc tranexamate compound |
| 01/06/1994 | WO1994000147A1 Use of enzymes, especially bromelain, in the treatment of diarrhoea |
| 01/06/1994 | WO1994000146A1 Treatment for sensitive teeth |
| 01/06/1994 | WO1994000122A1 Use of condensed bis-(3,4-dihydro-pyridinyl)methane for treating crohn's disease, colitis ulcerosa, chronic inflamatory processes and as an antiproliferative |
| 01/06/1994 | WO1994000113A2 Medicaments containing 5-ht4 receptor antagonists |
| 01/06/1994 | WO1994000101A1 Prophylactic and therapeutical preparation against caries |
| 01/06/1994 | WO1993015207A3 Hepatitis therapeutics |
| 01/06/1994 | CA2138954A1 Pharmaceutical pyridine compounds |
| 01/06/1994 | CA2138791A1 9-aminopyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinolines and their use in the preparation of pharmaceutical compositions |
| 01/06/1994 | CA2138788A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
| 01/06/1994 | CA2138780A1 Prophylactic and therapeutical preparation against caries |
| 01/06/1994 | CA2138167A1 Use of condensed bis-(3,4-dihydro-1-pyridinyl)methanes for treating crohn's disease, ulcerative colitis, chronic inflammatory processes and as antiproliferative agents |
| 01/06/1994 | CA2137674A1 Use of enzymes, especially bromelain, in the treatment of diarrhoea |
| 01/05/1994 | EP0577024A1 3,4,5 substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
| 01/05/1994 | EP0576420A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it. |
| 01/05/1994 | EP0282547B1 Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein |
| 01/05/1994 | DE4221054A1 Präparat zur prophylaktischen und therapeutischen Behandlung von Karies sowie Verfahren zum Herstellen desselben Of the same compound for the prophylactic and therapeutic treatment of caries as well as methods for preparing |
| 01/05/1994 | CN1023409C Production method of nutritive liquid |
| 01/05/1994 | CN1023402C Preparation of serotonin antagonists |
| 01/05/1994 | CN1023399C Preparation of 8-substituted-2-aminotetralines |
| 01/04/1994 | US5276014 Human growth factor |
| 01/04/1994 | US5275824 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 01/04/1994 | US5275822 Dry, uniform, free-flowing granular carbohydrate agglomerate; hydrocarbon, mineral or silicone oils containing silica |
| 01/04/1994 | US5275805 Inhibitors of plaque in mouths with mixtures of salicylanilide and nonionic surfactants |
| 01/04/1994 | CA1325809C Phenylene furyl, and thienyl leukotriene b_ analogues |
| 01/02/1994 | CA2099445A1 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 12/29/1993 | EP0576357A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/29/1993 | EP0575846A2 Food and feedstuff containing lipase inhibitors |
| 12/29/1993 | EP0575754A1 Pyridyl-1,2,5-oxadiazol-2-oxide-carbonamides for the treatment of NO-dependent disfunctions like angina pectoris and erection disorders |
| 12/29/1993 | EP0575749A2 Use of potassium-channel activators for the manufacture of a medicament for the treatment of gastrointertinal ulcers |
| 12/29/1993 | EP0575484A1 Method for promoting tissue repair and regeneration |
| 12/29/1993 | EP0575482A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 12/29/1993 | EP0575362A1 TETRAHYDROTHIENO(2,3-c)PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION |
| 12/29/1993 | EP0516729B1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them |
| 12/28/1993 | US5273984 Salts formed between basic histamine H2 -receptor antagonists and bismuth complexes |
| 12/28/1993 | US5273983 2-Piperidinylmethylcyclohexylaminocarbonyl-substituted benzene |
| 12/28/1993 | US5273904 Apparatus for purifying islets of Langerhans |
| 12/28/1993 | CA1325600C Anticariogenic compositions |
| 12/28/1993 | CA1325592C Use of antigenic substances for the prophylaxis or therapy of disorders and diseases within the gastrointestinal tract of animals and humans |
| 12/23/1993 | WO1993025582A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 12/23/1993 | WO1993025558A1 2-aminoethanesulfonic acid/zinc complex compound |
| 12/23/1993 | WO1993025547A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 12/23/1993 | WO1993025227A1 Use of growth factor igf-ii |
| 12/23/1993 | WO1993025226A1 Use of growth factor igf-i and/or igf-ii |
| 12/23/1993 | WO1993025214A1 Veterinary rehydration product |
| 12/23/1993 | DE4219782A1 New benzimidazol-1-yl-methyl-bi:phenyl derivs. |
| 12/23/1993 | CA2137469A1 Veterinary rehydration product |
| 12/23/1993 | CA2114420A1 Use of growth factor igf-ii |
| 12/23/1993 | CA2114419A1 Use of growth factor igf-i and/or igf-ii |
| 12/22/1993 | EP0575020A1 Non-aqueous liquid antibacterial oral composition exhibiting improved uptake on dental tissue surfaces |
| 12/22/1993 | EP0574906A2 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing the same |
| 12/22/1993 | EP0574487A1 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b |
| 12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| 12/21/1993 | US5272147 Pyrazolopyrimidinone antianginal agents |
| 12/21/1993 | US5272143 6-oxoazepinoindole compounds, and pharmaceutical compositions containing them |
| 12/20/1993 | CA2098074A1 Non-aqueous liquid antibacterial oral composition exhibiting improved uptake on dental tissue surfaces |
| 12/18/1993 | CA2098562A1 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing the same |
| 12/15/1993 | EP0573848A2 Bile-acid derivatives, a process for their production and their use as medicines |
| 12/15/1993 | CN1079469A New compounds |
| 12/15/1993 | CN1079466A 4- or 5-(thio)acylimino- and (Sulfinyl) amidopyridine and their pyrindine-N-oxide |
| 12/14/1993 | US5270365 Prevention and treatment of periodontal disease with alendronate |
| 12/14/1993 | US5270335 Administering a dioxabicyclo(3.3.0)octane |
| 12/14/1993 | US5270031 Dentinal desensitizing compositions |
| 12/14/1993 | CA1325192C Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component |
| 12/12/1993 | CA2096266A1 Method for the prophylaxis and/or treatment of ulceractive gastrointestinal conditions using a potassium activator and compositions for same |
| 12/09/1993 | WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor |
| 12/09/1993 | WO1993024521A1 Bpc peptides, their preparation and use |
| 12/09/1993 | WO1993024509A1 Erythromycin derivative |
| 12/09/1993 | WO1993024498A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
| 12/09/1993 | WO1993024492A1 Spiro-oxetanes, process for preparing the same and medicaments |
| 12/09/1993 | WO1993024485A1 Oxazole derivatives and their use as antiulcer agents and h2-receptor antagonist |
| 12/09/1993 | WO1993024475A1 Sulphamide derivatives as metalloproteinase inhibitors |